A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of renal function on the biological
activity of telavancin using blood samples obtained from subjects with normal renal function,
severe renal impairment, and end stage renal disease.
Phase:
Phase 1
Details
Lead Sponsor:
Cumberland Pharmaceuticals Theravance Biopharma Antibiotics, Inc.